Arthur C Lee, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · County of Santa Clara · Providence Health and Services - Washington
Hospitals listed: Providence St Mary Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lee’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence G40110 · Current
Licensed to practise in California · since 1979 · expires 2026-11-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence St Mary Medical CenterWalla Walla, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 4 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.247, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence St Mary Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 3 better, 7 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.247 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.96) · 478 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.44 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 196.03 (138.11 to 253.96) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 181 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 334 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.5 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,425 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.13 to 0.56) · 3,439 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 3,343 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.57 (0.3 to 4.84) · 762 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.46 (0 to 3.08) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.71 to 3.95) · 722 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.36 (0.06 to 16.65) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.24 to 9.2) · 199 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 143 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.25 (0 to 1.11) · 2,827 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 59 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.589 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 175 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -21.5 · 181 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9 · 353 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.5 · 317 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 304 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.2 (5 to 10.3) · 165 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (6.9 to 12.8) · 165 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 65 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 101 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15 (11.7 to 19.4) · 1,148 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 610 cases | No different | Jan 2024 – Dec 2024 |
What patients said (457 patients answered, 26% of those asked)
| Cleanliness | 5 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 83% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 80% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$98,918
Medicare paid this office $98,918 for 270 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 52 | $25,345 | $402 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 76 | $12,871 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 80 | $8,112 | $101 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,084 | $394 |
| Short return visit (20+ min) | 74 | $5,996 | $61 |
See all 15 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 52 | $25,345 | $402 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 76 | $12,871 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 80 | $8,112 | $101 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,084 | $394 |
| Short return visit (20+ min) | 74 | $5,996 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 78 | $3,772 | $48 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,697 | $61 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 33 | $2,484 | $71 |
| Hospital discharge day management, 30 minutes or less | 15 | $952 | $63 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $923 | $38 |
| Ultrasound of heart, follow-up | 29 | $537 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $294 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $137 | $5 |
| Heart muscle strain imaging | 11 | $89 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $55 | $2 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 110 | More than 97% of doctors who do this |
| Pacemaker insertion or repair | 63 | More than 93% of doctors who do this |
Who their Medicare patients are
270 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 20% · Women 46% · Also on Medicaid 19% · Health risk score 1.82. Above the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 74% · Heart failure 54% · Atrial fibrillation 44% · Diabetes 43% · Chronic kidney disease 38% · Depression 28% · COPD 26% · Stroke 16% · Cancer 14% · Dementia 10%.
The office billed $456,402, Medicare allowed $126,342 and paid $98,918; for 833 services of 66 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 270 | 833 | 76 | 1.82 | $456,402 | $98,918 |
| 2023 | 185 | 676 | 77 | 1.55 | $358,552 | $81,681 |
| 2022 | 211 | 850 | 77 | 1.74 | $430,564 | $107,493 |
| 2021 | 237 | 815 | 76 | 1.97 | $369,179 | $94,781 |
| 2020 | 275 | 936 | 76 | 1.82 | $419,329 | $119,629 |
| 2019 | 164 | 507 | 78 | 1.84 | $224,033 | $58,945 |
| 2018 | 55 | 147 | 78 | 1.49 | $57,945 | $17,648 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 37 | $16,057 | $357 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 48 | $6,990 | $137 |
| Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | 13 | $6,978 | $465 |
| Short return visit (20+ min) | 70 | $6,729 | $67 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,488 | $499 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,035 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 49 | $2,392 | $49 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 30 | $2,382 | $70 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,160 | $90 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,117 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,109 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,496 | $136 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $1,164 | $39 |
| Return visit (30+ min) | 16 | $935 | $55 |
| Ultrasound of heart, follow-up | 24 | $525 | $18 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $117 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $48 | $2 |
2022: 19 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 46 | $23,529 | $386 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 63 | $10,531 | $162 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 18 | $9,608 | $506 |
| Return visit (30+ min) | 53 | $7,785 | $95 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,983 | $415 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $4,228 | $47 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 53 | $4,206 | $76 |
| Short return visit (20+ min) | 42 | $3,689 | $67 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $3,542 | $236 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $3,480 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,462 | $107 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 24 | $1,879 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,728 | $157 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,348 | $84 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,329 | $31 |
| Ultrasound of heart, follow-up | 21 | $526 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $131 | $10 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $104 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $48 | $2 |
2021: 19 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 40 | $23,553 | $386 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $8,256 | $165 |
| Return visit (30+ min) | 58 | $7,514 | $94 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 14 | $7,412 | $529 |
| Short return visit (20+ min) | 68 | $6,151 | $71 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,066 | $422 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 57 | $4,657 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,575 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | $4,072 | $45 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 28 | $2,771 | $99 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,555 | $213 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,290 | $143 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $2,208 | $184 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 28 | $1,375 | $31 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,031 | $86 |
| Ultrasound of heart, follow-up | 11 | $206 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $65 | $5 |
| Insertion of needle into vein for collection of blood sample | 12 | $36 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $30 | $2 |
2020: 18 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 58 | $31,063 | $420 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 20 | $10,937 | $547 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 62 | $10,580 | $163 |
| Return visit (30+ min) | 95 | $8,822 | $79 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $8,237 | $162 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $6,087 | $435 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,544 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,227 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 94 | $5,070 | $53 |
| Short return visit (20+ min) | 52 | $3,527 | $58 |
| Critical care, first 30-74 minutes | 11 | $2,193 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,885 | $86 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,416 | $79 |
| Hospital discharge day management, more than 30 minutes | 16 | $1,414 | $88 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 16 | $975 | $61 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $580 | $32 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | $500 | $10 |
| Ultrasound of heart, follow-up | 12 | $299 | $21 |
2019: 11 services
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,195 | $388 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $7,167 | $189 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,031 | $419 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,117 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $3,990 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 76 | $3,954 | $51 |
| Return visit (30+ min) | 32 | $3,726 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,550 | $159 |
| Short return visit (20+ min) | 22 | $1,379 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $916 | $76 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $434 | $10 |
2018: 4 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $2,232 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $1,690 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,161 | $58 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $969 | $81 |
Medicaid work
$280 in 2020
Medicaid paid $280 for 12 billed services this clinician did in 2020, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $280 |
| 2020 | 12 | 1 | 12 | $280 |
Drugs they prescribed that Part D paid
$70,294
Pharmacies billed $70,294 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 521) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
441 generic and 80 brand-name prescriptions · $70,294 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 13 | $16,384 | $1,260 |
| Brilinta | 27 | $14,428 | $534 |
| Clopidogrel | 115 | $1,885 | $16 |
| Metoprolol | 96 | $1,307 | $14 |
| Atorvastatin | 69 | $746 | $11 |
See all 11 drugs
| Eliquis | 13 | $16,384 | $1,260 |
| Brilinta | 27 | $14,428 | $534 |
| Clopidogrel | 115 | $1,885 | $16 |
| Metoprolol | 96 | $1,307 | $14 |
| Atorvastatin | 69 | $746 | $11 |
| Isosorbide Mononitrate Er | 13 | $309 | $24 |
| Nitroglycerin | 14 | $170 | $12 |
| Losartan | 23 | $122 | $5 |
| Spironolactone | 12 | $102 | $9 |
| Lisinopril | 28 | $86 | $3 |
| Carvedilol | 16 | $84 | $5 |
Year by year
| 2024 | 521 | 98 | 0% (0) | 15% | $70,294 |
| 2023 | 465 | 83 | 0% (0) | 17% | $85,830 |
| 2022 | 453 | 88 | None | 11% | $58,029 |
| 2021 | 503 | 106 | None | 7% | $30,206 |
| 2020 | 257 | 72 | 0% (0) | 10% | $22,538 |
| 2019 | 130 | 29 | None | 18% | $9,755 |
| 2018 | 23 | None | 0% (0) | None | $1,644 |
| 2017 | 45 | 14 | 0% (0) | 29% | $1,382 |
| 2016 | 96 | 27 | None | 26% | $3,286 |
| 2015 | 105 | 30 | None | 25% | $4,165 |
| 2014 | 99 | 37 | None | 13% | $4,896 |
| 2013 | 144 | 49 | 0% (0) | 19% | $10,448 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Brilinta | 35 | $31,114 | $889 |
| Praluent | 12 | $6,306 | $526 |
| Metoprolol | 72 | $1,426 | $20 |
| Atorvastatin | 76 | $1,362 | $18 |
| Clopidogrel | 73 | $1,273 | $17 |
| Nitroglycerin | 21 | $626 | $30 |
| Isosorbide Mononitrate Er | 12 | $392 | $33 |
| Lisinopril | 28 | $274 | $10 |
| Losartan | 21 | $174 | $8 |
| Carvedilol | 11 | $62 | $6 |
2022: 10 drugs
| Brilinta | 15 | $18,640 | $1,243 |
| Praluent | 13 | $6,535 | $503 |
| Atorvastatin | 79 | $1,688 | $21 |
| Metoprolol | 72 | $1,497 | $21 |
| Clopidogrel | 87 | $1,210 | $14 |
| Nitroglycerin | 15 | $456 | $30 |
| Carvedilol | 16 | $280 | $18 |
| Lisinopril | 22 | $211 | $10 |
| Losartan | 18 | $168 | $9 |
| Furosemide | 16 | $116 | $7 |
2021: 10 drugs
| Metoprolol | 79 | $1,705 | $22 |
| Atorvastatin | 101 | $1,546 | $15 |
| Clopidogrel | 112 | $1,444 | $13 |
| Rosuvastatin | 14 | $901 | $64 |
| Nitroglycerin | 22 | $374 | $17 |
| Losartan | 16 | $275 | $17 |
| Carvedilol | 28 | $232 | $8 |
| Lisinopril | 18 | $81 | $5 |
| Furosemide | 14 | $61 | $4 |
| Metoprolol | 12 | $59 | $5 |
2020: 6 drugs
| Atorvastatin | 62 | $1,048 | $17 |
| Metoprolol | 35 | $743 | $21 |
| Nitroglycerin | 18 | $679 | $38 |
| Clopidogrel | 39 | $529 | $14 |
| Lisinopril | 16 | $185 | $12 |
| Carvedilol | 13 | $107 | $8 |
2019: 5 drugs
| Brilinta | 13 | $6,532 | $502 |
| Metoprolol | 13 | $221 | $17 |
| Atorvastatin | 15 | $179 | $12 |
| Clopidogrel | 12 | $129 | $11 |
| Metoprolol | 11 | $63 | $6 |
2017: 1 drug
| Clopidogrel | 23 | $727 | $32 |
2016: 2 drugs
| Clopidogrel | 43 | $1,627 | $38 |
| Atorvastatin | 24 | $1,071 | $45 |
2015: 2 drugs
| Clopidogrel | 55 | $2,826 | $51 |
| Atorvastatin | 22 | $961 | $44 |
2014: 1 drug
| Clopidogrel | 52 | $2,697 | $52 |
2013: 3 drugs
| Clopidogrel | 75 | $5,166 | $69 |
| Atorvastatin | 12 | $542 | $45 |
| Metoprolol | 12 | $105 | $9 |
Money from drug and device companies
$3,368 in 2025
| 2025 | 6 | 47 | None | $3,368 |
| 2024 | 7 | 33 | None | $1,753 |
| 2023 | 8 | 24 | None | $1,413 |
| 2022 | 3 | 16 | None | $581 |
| 2021 | 7 | 31 | None | $3,022 |
| 2020 | 5 | 19 | None | $2,343 |
| 2019 | 7 | 43 | $25,800 | $31,731 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Aveir | $1,647 | 14 payments
|
| Abiomed | None | $586 | 13 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $517 | 7 payments
|
| Medtronic | Linq II | $409 | 7 payments
|
| Boston Scientific | Avvigo Guidance System | $185 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $24 | 1 payment
|
See all 46 published payments
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-17 | Jardiance | $24 |
| Medtronic | Meals · 2025-12-05 | Linq II | $30 |
| Abiomed | Meals · 2025-12-04 | None | $111 |
| Medtronic | Meals · 2025-11-18 | Linq II | $17 |
| Abiomed | Meals · 2025-11-11 | None | $5 |
| Abiomed | Meals · 2025-10-29 | None | $5 |
| Abiomed | Meals · 2025-10-16 | None | $46 |
| Abbott Laboratories | Meals · 2025-10-16 | Aveir | $112 |
| Boston Scientific | Meals · 2025-10-15 | Avvigo Guidance System | $24 |
| Abbott Laboratories | Meals · 2025-09-14 | Aveir | $129 |
| Shockwave Medical | Meals · 2025-09-03 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $111 |
| Boston Scientific | Meals · 2025-09-02 | Avvigo Guidance System | $13 |
| Shockwave Medical | Meals · 2025-08-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $89 |
| Shockwave Medical | Meals · 2025-08-28 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $129 |
| Medtronic | Meals · 2025-08-28 | Linq II | $107 |
| Boston Scientific | Meals · 2025-08-26 | Avvigo Guidance System | $107 |
| Abbott Laboratories | Meals · 2025-07-25 | Aveir | $117 |
| Shockwave Medical | Meals · 2025-07-23 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $22 |
| Abiomed | Meals · 2025-07-11 | None | $81 |
| Medtronic | Meals · 2025-07-09 | Cobalt Dr Mri Surescan | $83 |
| Medtronic | Meals · 2025-06-04 | Linq II | $52 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $123 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $48 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $60 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $101 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $123 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $234 |
| Abiomed | Meals · 2025-05-09 | None | $32 |
| Abiomed | Meals · 2025-05-08 | None | $8 |
| Abiomed | Meals · 2025-05-07 | None | $53 |
| Medtronic | Meals · 2025-05-07 | Micra | $47 |
| Abbott Laboratories | Meals · 2025-04-24 | Aveir | $8 |
| Abbott Laboratories | Meals · 2025-04-18 | Aveir | $149 |
| Abiomed | Meals · 2025-04-08 | None | $4 |
| Abiomed | Meals · 2025-03-22 | None | $15 |
| Abiomed | Meals · 2025-03-19 | None | $98 |
| Abbott Laboratories | Travel · 2025-03-18 | Aveir | $260 |
| Abbott Laboratories | Travel · 2025-03-18 | Aveir | $174 |
| Abbott Laboratories | Travel · 2025-03-18 | Aveir | $9 |
| Boston Scientific | Meals · 2025-03-04 | Avvigo Guidance System | $41 |
| Abiomed | Meals · 2025-02-13 | None | $32 |
| Medtronic | Meals · 2025-02-13 | Symplicity G3 | $73 |
| Shockwave Medical | Meals · 2025-02-11 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $28 |
| Abiomed | Meals · 2025-01-17 | None | $96 |
| Shockwave Medical | Meals · 2025-01-15 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $27 |
| Shockwave Medical | Meals · 2025-01-15 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $111 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,753
| Abiomed | Impella | $728 | 14 payments
|
| Inari Medical | Flowtriever Catheter, S | $502 | 4 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $226 | 6 payments
|
| Penumbra | Penumbra System | $110 | 1 payment
|
| Boston Scientific | Avvigo Guidance System | $106 | 5 payments
|
| Medtronic | Onyx Frontier | $48 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $32 | 1 payment
|
2023: $1,413
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $582 | 5 payments
|
| Boston Scientific | Avvigo Guidance System | $274 | 9 payments
|
| Teleflex | Guideliner | $184 | 1 payment
|
| Medtronic | Onyx Frontier | $152 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $117 | 1 payment
|
| Philips Electronics North America | (6574) Coronary Other | $48 | 1 payment
|
| Abbott Laboratories | Jot Dx | $40 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $15 | 1 payment
|
2022: $581
| Boston Scientific | Avvigo Guidance System | $436 | 11 payments
|
| Medtronic | Micra | $80 | 3 payments
|
| Abbott Laboratories | Aveir | $65 | 2 payments
|
2021: $3,022
| Abbott Laboratories | Quadra Allure Mp Rf Crt Pacemkr | $1,503 | 13 payments
|
| Medtronic | Micra | $1,021 | 8 payments
|
| Boston Scientific | General Pain Management | $291 | 6 payments
|
| Abiomed | Impella | $116 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $63 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
| Chiesi USA | Kengreal | $13 | 1 payment
|
2020: $2,343
| Medtronic Vascular | Resolute | $2,217 | 12 payments
|
| Boston Scientific | Comet | $73 | 3 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26 | 2 payments
|
| Abbott Laboratories | Cardiomems Hf System | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $13 | 1 payment
|
2019: $31,731
| Boston Scientific | General Vascular Access | $24,158 | 11 payments
|
| Abbott Laboratories | Hi-Torque Pilot Guide Wire | $5,016 | 11 payments
|
| Medtronic Vascular | Resolute | $2,123 | 16 payments
|
| Novartis Pharmaceuticals | Entresto | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $124 | 1 payment
|
| Philips Electronics North America | Igt D Coronary | $114 | 1 payment
|
| Aziyo Biologics | Ecm Patch,Pouch | $71 | 2 payments
|
Professional record
- NPI
- 1194899419
- Licence
- CA G40110California G40110: Current · expires 2026-11-30
- Trained
- University of California, Davis School of Medicine, 1978
- Group
- County of Santa Clara · Providence Health and Services - Washington
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G401100
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-11-20
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.